Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00066144Phase 2Completed
Phase 2, randomised, double-blind trial of cimicifuga racemosa and Red clover extract in menopause and hot flashes (4 arms), sponsored by National Center for Complementary and Integrative Health. Primary endpoint: Reduction in frequency and intensity of vasomotor symptoms (hot flashes and night sweats) at 12 months. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00066144.